Sign In
Buy SNY
$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
02:32pm, Tuesday, 20'th Jul 2021
EMA's human medicines committee has kicked off a rolling review of a COVID-19 vaccine from Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NASDAQ: GSK), which started a 35,000-patient Phase
Sanofi's Oral Treatment For Sleeping Sickness Gets FDA Approval
01:19pm, Monday, 19'th Jul 2021
The FDA has approved Sanofi SA's (NASDAQ: SNY) fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei gambiense form of sleeping sickness in patients six years of ag
Is This Coronavirus Stock Undervalued?
06:30am, Wednesday, 14'th Jul 2021
This biotech giant might be down, but it isn't out just yet.
Sanofi announces Paris 2024 Premium partnership for the Olympic and Paralympic Games in Paris
01:30am, Tuesday, 13'th Jul 2021
Press release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY)
IDNA: Genetics Now Have A Lot Of Influence On Healthcare
03:12am, Saturday, 10'th Jul 2021
IDNA: Genetics Now Have A Lot Of Influence On Healthcare
Sanofi (SNY) is a Top Dividend Stock Right Now: Should You Buy?
12:47pm, Thursday, 08'th Jul 2021
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Sanofi (SNY) have what it takes?
Is Sanofi (SNY) Stock Undervalued Right Now?
12:47pm, Thursday, 08'th Jul 2021
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
WHO Guidelines Put Spotlight on Arthritis Drugs Actemra & Kevzara
12:02pm, Thursday, 08'th Jul 2021
The latest guideline update by the WHO includes the use of arthritis drugs like Roche's (RHHBY) Actemra and Sanofi's (SNY) Kevzara for the treatment of severe COVID-19.
Sanofi, GSK Get Nod For Late-Stage COVID-19 Vaccine Trial In India
09:19am, Thursday, 08'th Jul 2021
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline Plc (NYSE: GSK) have received approval from the Drug Controller General of India (DCGI) for a late-stage clinical trial of their protein-based COVID-19
WHO Recommends IL-6 Drugs From Sanofi, Roche For Critically-Ill COVID-19 Patients
11:47am, Wednesday, 07'th Jul 2021
The World Health Organization (WHO) has endorsed Interleukin-6 (IL-6) receptor antagonists combined with corticosteroids to treat severe COVID-19 cases. Patients severely or critically ill with COVI
WHO recommends Roche, Sanofi/Regeneron drugs as COVID-19 treatments, calls for lower prices
07:48am, Wednesday, 07'th Jul 2021
The World Health Organization began recommending the use of medicines called interleukin-6 receptor blockers as COVID-19 treatments for the severely ill, based on the findings of a large clinical stud
As Sanofi launches its Covid vaccine by December, should you invest now?
07:29am, Wednesday, 07'th Jul 2021
French pharmaceutical giant Sanofi SA (LON:0O59) said Monday its Covid-19 vaccine developed in partnership with UK Pharma GlaxoSmithKline Plc (NYSE:GSK) could be ready for roll-out by December. Sanofi
102 'Top Dividend Stocks On Earth' July Update
07:04am, Sunday, 04'th Jul 2021
Kiplinger "insights for investors" online, first listed 91 "Top Dividend Stocks From Around The World" 7/13/20. Two recent Kiplinger articles provided 102 Top Dividend Stocks on Earth as of 7/1/21. 39
Now on Sale at Walmart: Insulin That's Cheaper Than Brands from Lilly, Sanofi, or Novo Nordisk
01:06pm, Tuesday, 29'th Jun 2021
The discount chain's private label sells at prices more than 50% lower than brand names made by Lilly, Sanofi, and Novo Nordisk.
Sanofi Invests To Build Internal Capabilities in mRNA
09:09am, Tuesday, 29'th Jun 2021
Sanofi SA (NASDAQ: SNY) is working towards its R&D approach around mRNA to accelerate the development and delivery of next-generation vaccines. The company will invest approximately €400 million p
